Skip to content
    T. Rowe Price logo

    T. Rowe Price

    Baltimore, Maryland, United StatesFounded 1937
    troweprice.comLinkedIn
    Mobility & TransportationE-Commerce & MarketplaceBiotech & Life SciencesFood & AgricultureData & AnalyticsFintechEnterprise SoftwareHealthcareAIConsumer

    T. Rowe Price, as a venture capital firm, focuses on identifying innovative companies with strong fundamentals and sustainable growth potential, aiming to compound wealth as these companies scale from early-stage to durable growth. Their strategy involves deep fundamental research and a long-term investment horizon, primarily in late-stage venture and growth equity across sectors like technology, consumer, financial services, healthcare, and industrials.

    Average disclosed round size is $584.0M (across 110 rounds with reported amounts).

    Find people at T. Rowe Price on Goldilocks AI

    Portfolio

    116

    Fund Size

    $1800B

    Top Stage

    Growth

    Last 12 Mo

    8

    Team

    Robert W. Sharps, CFA

    Robert W. Sharps, CFA

    Chair of the Board, Chief Executive Officer and President

    Scott Keller, CFA, CAIA®

    Scott Keller, CFA, CAIA®

    Head, Americas, APAC EMEA Distribution

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    116 investments
    CompanyRoundAmountDate
    Cross River Bank logoCross River BankSeries C$50MMar 2026
    Cyclic Materials logoCyclic MaterialsSeries C$75MJan 2026
    Physical Intelligence logoPhysical IntelligenceGrowth$600MNov 2025
    Ramp logoRampGrowth$300MNov 2025
    Crusoe logoCrusoeSeries E$1.4BOct 2025
    Galvanize Therapeutics logoGalvanize TherapeuticsSeries C$100MSep 2025
    Nuro logoNuroSeries E$203MAug 2025
    OpenAI logoOpenAIGrowth$8.3BAug 2025
    Nuro logoNuroSeries E$106MApr 2025
    Arbor Biotechnologies Inc logoArbor Biotechnologies IncSeries C$73.9MMar 2025
    KoBold Metals logoKoBold MetalsSeries C$537MJan 2025
    SandboxAQ logoSandboxAQGrowth$300MDec 2024
    Waymo logoWaymoSeries C$5.6BNov 2024
    Lightmatter logoLightmatterSeries D$400MOct 2024
    Clio logoClioSeries F$900MJul 2024
    Bluejay Therapeutics logoBluejay TherapeuticsSeries C$182MMay 2024
    LLambda AIGrowth$320MFeb 2024
    Stash logoStashSeries B$40MOct 2023
    Chroma Medicine logoChroma MedicineSeries B$135MMar 2023
    Celonis logoCelonisSeries D$1BAug 2022
    Cross River Bank logoCross River BankGrowth$600MMar 2022
    Eikon Therapeutics logoEikon TherapeuticsSeries B$517.8MJan 2022
    Socure logoSocureSeries E$450MNov 2021
    Arbor Biotechnologies Inc logoArbor Biotechnologies IncSeries B$215MNov 2021
    Canva logoCanvaGrowth$200MSep 2021
    Page 1 of 5

    Top Co-Investors

    Tiger Global Management24 shared
    Fidelity Investments14 shared
    Andreessen Horowitz13 shared
    T. Rowe Price Associates, Inc.10 shared
    Sequoia Capital10 shared
    Franklin Templeton10 shared
    Dragoneer Investment Group9 shared
    Coatue Management9 shared
    Baillie Gifford8 shared
    NEA (New Enterprise Associates)8 shared
    GV (Google Ventures)8 shared
    Bessemer Venture Partners8 shared
    Greylock Partners7 shared
    Index Ventures7 shared
    BlackRock7 shared
    Fidelity Management & Research Company6 shared
    Lightspeed Venture Partners6 shared
    Wellington Management6 shared
    Temasek Holdings6 shared
    General Catalyst6 shared

    Last updated: 10 April 2026